EFFECT OF SMOKING ON HOMOCYSTEINE, VITAMIN B12 AND FOLIC ACID LEVLES IN THE PATIENTS OF ACUTE MYOCARDIAL INFARCTION
Keywords:
Smoking, homocysteine, B vitamins, acute, myocardial infarctionAbstract
Objectives: To evaluate levels of serum homocysteine, vitamin B12 and folic acid in the smoker and non smokers of
acute myocardial infarction.
Material and Method: A case control study of 200 patients of acute myocardial infarction between the age of 20-60
years and an equal number of age and sex matched controls were carried out during January 2007 to December
2008. Serum homocysteine levels were determined on Abbott Immunoassay Analyzer (IMX) and determination of B
vitamins was done on HPLC.
Results: Mean age of the smoker patients of acute myocardial infarction was 41.72 ± 2.43 years, while that of never
smoker patients was 50.56 ± 3.28 years. In both cases and controls current smokers had higher homocysteine levels
but patients showed intermediate hyperhomocysteinemia (31.83 ± 1.09 and 15.94 ± 2.65 ? mol/L) respectively in the
patients and controls. Never smoker patients had lower homocysteine levels as compared to smokers and showed
moderate hyperhomocysteinemia (19.62 ± 2.14 ? mol/L). Never smoker controls showed normal homocysteine
levels. Current smokers had lower levels of vitamin B12 and folic acid (103.43 ± 1.39 pg / mL and 3.48 ± 2.31 ng/mL
respectively) as compared to smoker controls and the patients who never smoked.
Conclusion: Smokers tend to have high homocysteine concentrations and low levels of vitamin B12 and folic acid,
which may result in sudden cardiovascular events.
Downloads
Published
How to Cite
Issue
Section
License
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.
